Wire · opportunities
Ladera Medical Presents Full FASTEN Results Showing Rapid Hemostasis and a Strong ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 22 November 2026 · Fusion42 review
Ladera Medical announced the full results of the FASTEN clinical trial demonstrating that its Large Bore Closure System achieves rapid hemostasis and a high safety profile in patients undergoing transfemoral TAVR/TAVI procedures, with 98.1% freedom from major access-site complications at 30 days and a mean time to hemostasis of 0.5 minutes.
This Wire brief sits within Fusion42's coverage of Medtech, and 3 sources have reported it.
◆ ◆ The Wire takeaway
You have a new option to close large femoral artery access sites with one device instead of several. This system can speed procedures and reduce complications in transfemoral TAVR, reshaping your approach to vascular closure.
◆ Coverage
3 sources · 22 Nov 2026
◆ Related on Wire
◆ Topics